We are live on ! Find out more
OXFD

Oxford Immunotec Global
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

71 hedge funds and large institutions have $280M invested in Oxford Immunotec Global in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

42% more capital inflows, than outflows

Capital inflows: $23.3M | Capital outflows: $16.4M

9% more funds holding

Funds holding: 65 → 71 (+6)

1.97% more ownership

Funds ownership: 90.17% → 92.14% (+2%)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
71
Holders Change
+6
Holders Change %
+9.23%
% of All Funds
1.43%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.08%
New
11
Increased
22
Reduced
24
Closed
5
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$2K

OXFD Hedge Fund Activity: Q3 2020 in Review

71 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global (OXFD) for Q3 2020, worth a combined $280M — down 8% from $304M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OXFD positions and 5 closed out — a net gain of 6 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Endurant Capital Management, adding an estimated $4.75M. The largest seller was Deerfield Management, cutting an estimated $2.88M.

  • 71 institutional investors held Oxford Immunotec Global (OXFD) as of Q3 2020, up from 65 in Q2 2020.
  • Funds reported $280M of Oxford Immunotec Global stock for Q3 2020, down 8% quarter-over-quarter.
  • 11 funds opened new Oxford Immunotec Global positions in Q3 2020 and 5 closed out, a net change of +6 holders.
  • The largest Oxford Immunotec Global buyer in Q3 2020 was Endurant Capital Management, an estimated $4.75M added.
  • The largest Oxford Immunotec Global seller in Q3 2020 was Deerfield Management, an estimated $2.88M sold.

Based on aggregated 13F filings for Q3 2020.